improve sleep apnea in patients with PH. In addition, oxygen therapy also improved exercise performance. Further studies are needed to corroborate the efficacy of these and other treatments.
Introduction
Precapillary pulmonary hypertension (PH) and right ventricular heart failure occur in certain patients with sustained hypoxemia due to obesity hypoventilation syndrome [1] and severe sleep-related hypoventilation, and in high-altitude residents suffering from chronic mountain sickness [2] . Whether precapillary PH may also develop as a consequence of intermittent hypoxemia during sleep such as in patients with obstructive sleep apnea (OSA) is controversial. While up to 50% of adults in Western countries are estimated to be affected by various severities of OSA [3] [4] [5] , only a minor fraction of these individuals are considered to suffer from precapillary PH [6] . Conversely, among patients with precapillary PH, either pulmonary arterial or chronic thromboembolic (WHO classes I or IV), a high prevalence of central sleep apnea (CSA) and OSA has been observed suggesting a pathophysiologic link [7] .
In patients with postcapillary PH due to severe left ventricular heart failure (WHO class II), Cheyne-Stokes respiration/CSA (CSR/CSA) is quite common and this association is considered to indicate a poor prognosis. Compared to sleep-disordered breathing (SDB) in the context of left ventricular failure, which has been the topic of a review article in this journal [8] , SDB in association with precapillary PH has gained much less attention. Therefore, the aim of the current review is to analyze the literature on this association with a particular focus on the pathophysiologic mechanisms linking SDB and precapillary PH. We further review the prevalence and importance of precapillary PH in patients with SDB and of SDB in patients with PH, and we analyze the prognostic and therapeutic implications of SDB in association with PH.
Mechanisms Linking Precapillary PH and SDB
During normal sleep, there is a fall in heart rate and systemic arterial blood pressure with lowest values in deep non-rapid eye movement (NREM) sleep [9] . In rapid eye movement (REM) sleep, pulmonary arterial pressure (PAP) becomes unstable and increases compared to NREM sleep [10] . However, no relevant differences in PAP were seen between the first and the second half of a night in healthy individuals, which may indicate a lack of dependence of PAP on NREM and REM sleep stage [11] .
Excessive rises in PAP and SDB may be mutually linked by either direct effects or via comorbid conditions ( Fig. 1 ). Thus, hypoxemia during sleep due to hypoventilation or apneas/hypopneas may induce PH through hypoxic and/ or hypercapnic pulmonary vasoconstriction and sympathetic activation as detailed below. Conversely, it has been suggested that precapillary PH associated with right ventricular failure may promote instability of ventilatory control leading to sleep apnea through similar mechanisms as in left ventricular failure with CSR/CSA [12] . Furthermore, patients suffering from SDB in association with other conditions predisposing to an elevated PAP such as chronic lung disease, in particular chronic obstructive pulmonary disease (COPD), chronic alveolar hypoventilation related to chest wall deformities or neuromuscular disease with respiratory muscle weakness, may be susceptible to developing precapillary PH. According to epidemiologic studies in overweight patients, both hypoxia and hypercapnia are associated with precapillary PH, although their relative significance has not been conclusively assessed [13] . Thus, in one study in obese patients with PH [14] , PaCO 2 was correlated with PAP; 3 months of treatment with noninvasive ventilation reduced both PaCO 2 and PAP. Since PaO 2 was also improved, the independent effect of hypercapnia could not be assessed. Nevertheless, other studies in preparations of pulmonary arteries [15] , animal models [16, 17] and healthy volunteers [18, 19] have suggested an independent effect of hypercapnia inducing PH by pulmonary vasoconstriction through an NO-mediated pathway and by enhanced vasoreactivity of pulmonary arteries. Thus, intermittent sleep-related hypoxemia and hypercapnia alone or in combination with chronic hypoxemia and structural alterations of the lung may predispose to precapillary PH, right ventricular dysfunction and failure. The paucity of conclusive data on this topic may be due to the complexity of measuring pressure and flow in the pulmonary circulation by right heart catheter. Novel echocardiographic and magnetic resonance imaging and other techniques may provide further insights into these interactions in the future [20, 21] . Various pathophysiologic mechanisms linking PH and SDB will be discussed in the following. Hypoxic and Hypercapnic Pulmonary Vasoconstriction. Hypoxic pulmonary vasoconstriction is an important mechanism that contributes to maintaining an adequate ventilation-perfusion relationship (V/Q) in the lungs [22] . Thus, reducing ventilation in a part of the lungs leads to regional hypoxia with vasoconstriction that reduces shunt perfusion. Motley and Cournand [23] showed that breathing a hypoxic gas mixture containing 10% oxygen induced a rise in PAP. Persistent pulmonary vasoconstriction due to hypoxia may result in vascular remodeling and thus chronic precapillary PH. As outlined above, hypercapnia may also promote pulmonary vasoconstriction in conjunction with or independent of hypoxia. Both hypoxia and hypercapnia are therefore considered to be responsible for the development of pre-capillary PH in chronic hypoventilation due to obesity or lung diseases [24] . Some animal studies have suggested that nocturnal intermittent hypoxia in OSA is sufficient to cause persistent daytime PH und right ventricular dysfunction [25] but this is debated in the case of human OSA. Some studies on this topic included patients with coexisting conditions such as COPD or obesity resulting in sustained hypoxemia by ventilation-perfusion mismatch, diffusion impairment or hypoventilation [26] [27] [28] [29] [30] , others were performed in sleep apnea patients without comorbidities [31] [32] [33] . It is conceivable that patients with chronic lung disease such as COPD that may cause hypoxemia and a reduced pulmonary vascular bed, or patients with hypoxemia due to obesity associated with hypoventilation may be at particular risk to develop pulmo- Sympathetic Overstimulation. In patients with OSA, breathing efforts against an occluded airway cause large fluctuations in systemic blood pressure associated with hypoxemia, arousals and surges of sympathetic tone [34] . Moreover, major rises in both systemic and PAP during long apneas in phasic REM sleep have been described ( Fig. 2 ) [10] . The large arterial pressure swings associated with sympathetic overstimulation in OSA patients induce vascular shear stress and promote endothelial dysfunction [35] [36] [37] . Repetitive hypoxia and reoxygenation may upregulate hypoxia-inducible factors, vascular endothelial growth factor and erythropoietin, and trigger inflammatory processes [38] . These mechanisms may lead to elevations in PAP that persist even during daytime and over prolonged time as suggested for the pathophysiology of systemic hypertension in OSA.
OSA and Precapillary PH
Increased Inspiratory Effort. In OSA, the increased inspiratory effort against an occluded airway causes large intrathoracic pressure swings that create mechanical stress on the aorta and the left ventricle and increase afterload contributing to the development of systemic hypertension and cardiovascular disease in affected patients. Acute right ventricular enlargement because of increased venous return may impair left ventricular filling. Together, these mechanisms may lead to an increased pulmonary venous pressure, and postcapillary PH [39] . Conceivably, similar mechanisms might also lead to elevated PAP. Negative intrathoracic pressure during OSA might additionally cause PAP to rise by increased pulmonary vascular resistance [40] . A similar mechanism has recently been documented in patients with COPD experiencing major increases in pleural pressure swings during exercise that were accompanied by rises in PAP [41] .
Precapillary PH and Ventilatory Instability
Several studies have shown that severe precapillary PH associated with right ventricular failure and low cardiac output may be associated with SDB including CSR/CSA as well as OSA, similar to what is observed in patients with severe left ventricular failure and postcapillary PH [7, 42, 43] . The mechanisms responsible for the destabilizing effect of PH on control of breathing remain elusive. However, factors that predispose to CSR/CSA in left ventricular failure may also be relevant in right ventricular failure. For example, increased chemosensitivity associated with sympathetic stimulation may promote an overshooting ventilatory response to apneas/hypopneas. Moreover, an excessive circulatory delay due to a reduced cardiac output in severe precapillary PH may prolong the time required to transport oxygenated blood from the lungs to the chemoreceptors so that the feedback to the respiratory center is desynchronized [8, 44, 45] . Patients with precapillary PH, especially those with right ventricular heart failure and fluid overload, may possibly exhibit nocturnal breathing instability through rostral fluid redistribution at night as suggested by studies in patients with systemic hypertension [46] .
Prevalence and Importance of PH in SDB
There is increasing evidence of an association of SBD with systemic hypertension, incidence of stroke, heart failure, myocardial infarction, arrhythmias and sudden cardiac death [47] [48] [49] . Similar data on potentially adverse effects of SDB in patients with PH are not available. A research of the literature on the prevalence of precapillary PH in patients with SDB unselected for the absence of comorbidities as well as in patients with concomitant lung and heart diseases has identified the studies summarized in Table 1 .
In observational case studies of OSA patients unselected for absence of comorbidities ( Table 1 , upper part), the prevalence of PH has varied largely between 17 and 60% [27, 50] . When studies excluded patients with coexisting lung and heart diseases, the prevalence of OSA-related PH was estimated at up to 40% ( Table 1 , lower part) [31, 32, [50] [51] [52] ; however, in only 2 of these studies [31, 51] was the current definition of PH (mean PAP >25 mm Hg) applied. The wide range of prevalence rates may be due to differences in patient selection, disease definition and methodological differences, i.e., invasive pressure measurement with right heart catheter versus Doppler echocardiography. The value and limitations of Doppler echocardiography in the evaluation of PH patients have been addressed in the recent ESC/ERS guidelines [53] . Additionally, using PAP cutoff values for defining the presence of PH that are different than the current one (mean PAP ≥ 25 mm Hg) might have confounded the prevalence rates. Data from appropriately powered epidemiologic studies using right heart catheter data and the current definition of PH are not available to date.
In a large sample of 220 patients with OSA [27] , 17% revealed a mean PAP of >20 mm Hg (i.e., this study used a cutoff for defining PH that was lower than the mean PAP ≥ 25 mm Hg required for the diagnosis of PH according to current standards). Some of these patients [13] studied a heterogeneous group of 100 patients with OSA. The mean daytime PAP was 21 mm Hg and the apnea/hypopnea index (AHI) varied between 20 and 100 events/h. Forty-two patients had a mean PAP >20 mm Hg (a definition of PH different from current standards). Several patients were hypoxemic and hypercapnic during daytime and some had impaired pulmonary function suggesting coexisting COPD. In addition, some patients were very obese; PaO 2 , PaCO 2 and FEV 1 explained 33% of the variation in PAP suggesting that the high prevalence of precapillary PH of 42% in this cohort may have been re- Several studies used definitions of precapillary pulmonary hypertension (PH) that are not consistent with the current definition of mPAP ≥25 mm Hg and PCWP <15 mm Hg, the criteria for PH are indicated for individual studies. OSA, obstructive sleep apnea; COPD, chronic obstructive pulmonary disease; mPAP, mean pulmonary artery pressure; AHI, apnea/hypopnea index; BMI, body mass index; CTEPH, chronic thromboembolic pulmonary hypertension; CSR, Cheyne-Stokes respiration; PFT, pulmonary function testing; SDB, sleep-disordered breathing; CPAP, nocturnal continuous positive airway pressure treatment; PCWP, pulmonary capillary wedge pressure. 71 lated to coexistent disorders and to the liberal PH definition of mean PAP >20 mm Hg at that time.
Sajkov et al. [51] compared a group of OSA patients with mildly elevated PAP still within the normal range (mean PAP of 22.8 mm Hg) with another group of patients with a similar degree of OSA but low normal PAP (mean PAP of 14.6 mm Hg). In both groups, no heart or lung disease could be found even by detailed examinations, but the patients with higher PAP had lower PaO 2 . The authors speculated that these patients had an excessive hypoxic response of the pulmonary vasculature that promoted the development of PH in combination with OSA.
To further corroborate the mechanisms involved in the rise of PAP in certain patients with OSA, Sajkov et al. [52] studied 32 OSA patients without any evidence of cardiac or pulmonary disease. Eleven of them had a mean PAP >20 mm Hg but a similar AHI, body mass index and daytime arterial blood gas values as the remainder of the patients with a mean PAP <20 mm Hg. Although both groups of OSA patients had normal spirometry, the patients with higher mean PAP had a reduced closing volume measured by the nitrogen washout technique. The difference between functional residual capacity and closing volume was negative indicating that some patients ex-perienced intermittent closure of peripheral airways during tidal breathing. This might have predisposed them to a V/Q mismatch and hypoxemia thereby contributing to elevated PAP. In the same group of OSA patients, Sajkov et al. [52] evaluated the hypoxic pulmonary vasoreactivity by exposing patients to an inspiratory fraction of oxygen (FiO 2 ) of 11, 21 and 50% while PAP was monitored. Patients with elevated PAP at baseline on room air above 20 mm Hg had a brisker response to changes in FiO 2 than patients with lower baseline mean PAP. In addition, challenges with dobutamin infusion were performed. With increases in cardiac output, PAP rose significantly more in patients with mean PAP >20 mm Hg at baseline compared to the rest of the patients. These findings were considered to be consistent with vascular remodeling in some of the OSA patients [52] ( Fig. 3 ) .
SDB in Patients with Precapillary PH
So far, the direct or indirect effects of SDB on precapillary PH had been discussed. There is evidence that the relation may also act in the opposite direction, so that precapillary PH may trigger SDB ( Fig. 1 ) . As many features of patients with left ventricular failure and SDB, such as low cardiac output, increased sympathetic tone, and arrhythmia, are also common in patients with precapillary PH and right ventricular failure, some authors have also looked at SDB in patients with precapillary PH of different origins. These studies are summarized in Table 2 . Schulz et al. [54] were the first to describe CSR/CSA in patients with pulmonary arterial hypertension (PAH; WHO class I). Patients had typical periodic breathing with waxing and waning of ventilation. Fourteen had an AHI of <20/h and 6 had an AHI >20/h with nearly exclusively central events consistent with CSR/CSA. In order to further evaluate the prevalence and type of sleep-related breathing disturbances in PH patients, we performed a prospective study in consecutive patients with either PAH or chronic thromboembolic pulmonary hypertension [7] . In none of these patients had SDB been suspected on clinical grounds and most of them had been treated for PAH/chronic thromboembolic pulmonary hypertension with various drugs for several months or years. A total of 38 patients were studied. In Figure 4 , the total AHI in each patient and the relation between central and obstructive events are shown. Eighteen patients or 47% had an elevated AHI of >10/h. The large majority had pre- 26 .6% had sleep apnea, AHI >10/h, of these 16.0 % had OSA, 10.6% had CSA PH, pulmonary hypertension; PAH, pulmonary arterial hypertension; CSR, Cheyne-Stokes respiration; CTEPH, chronic thromboembolic pulmonary hypertension; mPAP, mean pulmonary artery pressure; SDB, sleep disordered breathing; OSA, obstructive sleep apnea; AHI, apnea/hypopnea index; BMI, body mass index dominant CSR but 4 patients also had more than 10 obstructive events per hour. No significant differences in hemodynamics, arterial blood gases or pulmonary function between the groups with and without increased AHI were found. Polysomnography and pulse oximetry were used to assess SDB in the study by Ulrich et al. [7] to evaluate the diagnostic accuracy of the simple technique in this setting. Although pulse oximetry had been proposed as part of the routine evaluation of patients with PH to detect nighttime hypoxemia [55] , oximetry alone revealed a poor diagnostic performance (area under the receiver operating characteristic curve of only 0.66 ± 0.14) in identifying patients with an AHI ≥ 10, when compared with polysomnography [7] . Thus, pulse oximetry alone cannot be recommended as diagnostic tool for SDB in PH patients. Whereas in some studies on the association of precapillary PH with SDB nocturnal hypoxemia without sleep apnea was the predominant finding [55, 56] , others found sleep apnea without severe persistent hypoxemia [7, 54] or a combination of both persistent hypoxemia and sleep apnea [42, 43] . In a most recent study in Kyrgyz highlanders, a high prevalence of mainly OSAs was found among individuals with high-altitude PH, a particular form of precapillary PH occurring in life-long residents at altitudes >2,500 m. This observation suggests that individuals exposed to the combined stimuli of chronic hypoxemia due to high-altitude residence and intermittent nocturnal hypoxemia due to sleep apnea may be more susceptible to PH compared to highlanders without sleep apnea [57] .
Treatment of PH in SBD
Tracheostomy and supplemental oxygen have been shown to reduce PAP in patients with COPD and nighttime hypoxemia [58] but this intervention (tracheostomy) is rarely performed nowadays. Limited data on effects of continuous positive airway pressure (CPAP) treatment in patients with OSA on PAP are available. In a case-control study by Alchanatis et al. [31] , 29 patients without evidence of pulmonary or cardiac disease were studied with Doppler echocardiography before and after 6 months of CPAP treatment. Of these 29 patients, 6 had mild precapillary PH. The control group consisted of 12 healthy subjects. Older subjects and those with increased body mass index in the OSA group were more prone to suffer from (generally mild) precapillary PH and 6 months of CPAP caused a significant fall in PAP in hyper-and normotensive patients pointing to OSA as an independent risk factor for the development of precapillary PH. In another study including patients with moderate to severe OSA, 4 months of CPAP significantly reduced the PAP, especially when the PAP was elevated at baseline [59] . Moreover, the pulmonary vascular response to hypoxia decreased after CPAP treatment [59] . In a randomized crossover trial in patients with OSA using sham or effective CPAP for 12 Supplemental nocturnal oxygen has been used in patients with nocturnal hypoxemia-related PH. In COPD patients, long-term home oxygen therapy did not improve survival in patients with mild to moderate hypoxemia or in those with arterial desaturation at night only [61] . It is uncertain whether this also applies to PH pa- CPAP and UPPP cohort differed largely in BMI at baseline PH, pulmonary hypertension; OSA(S), obstructive sleep apnea (syndrome); CPAP, continuous positive airway pressure; AHI, apnea/ hypopnea index; mPAP, sPAP, mean and systolic pulmonary artery pressure estimated by echocardiography; BMI, body mass index; BP, blood pressure; CTEPH, chronic thromboembolic pulmonary hypertension; PAH, pulmonary arterial hypertension; SDB, sleep disordered breathing; UPPP, uvulopalatopharyngoplasty. tients with nighttime hypoxemia and SBD. In the only randomized, placebo-controlled study in patients with precapillary PH and SDB nocturnal oxygen therapy improved the 6-min walk distance already after 1 week ( Fig. 5 ) and reduced the AHI [62] . In turn, acetazolamide (2 × 250 mg tablets/day) reduced the AHI to a similar degree but did not change the 6-min walk distance [62] . Whether selected patients with PAH and SDB may benefit from specific PH therapy has not been studied. Table 3 gives an overview of interventional studies with CPAP or oxygen in patients with SBD associated precapillary PH.
Conclusions
Available data suggest that about one half of patients with OSA unselected for the absence of comorbidities have intermittent or sustained elevations of the PAP and that up to one half of patients with precapillary PH suffer from SBD. Several pathophysiologic mechanisms predispose patients with SBD to precapillary PH. However, precapillary PH in OSA not associated with any other conditions leading to hypoxemia seems to be rare. Optimized therapy of any comorbidity such as COPD and obesity seems to be crucial. For the remaining patients with both SDB and PH but without comorbidity, positive pressure ventilation or oxygen might be beneficial in terms of lowering the PAP but this has not been evaluated in rigorous randomized trials. In patients with precapillary PH associated with SDB nocturnal oxygen supplementation has improved exercise performance and SDB in one trial [62] but long-term studies that confirm these findings are lacking. The role of CPAP or other modes of positive pressure ventilation and of PH specific drugs in the treatment of patients with precapillary PH and central or OSA requires further evaluation in randomized trials.
